The Role of HER2 in Breast Cancer and Treatment Goals for HER+ Metastatic Breast Cancer Patients

Tiffany A. Traina, MD; Vijayakrishna Gadi, MD, PhD, and Heather McArthur, MD, underscore the importance of testing all early-stage and breast cancer patients for HER2 positivity to inform and guide optimal therapeutic decision-making.

Related Keywords

Vijayakrishna Gadi ,Tiffanya Traina ,Heather Mcarthur , ,Treatment Approach ,Positive Breast Cancer ,Breast Cancer ,Treatment Goals ,Metastatic Breast Cancer ,